A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levels

Internal Medicine

Volumn 49, Issue 16, 2010, Pages 1783-1786

  Kuno, Yoshihiro ^a   Iyoda, Masayuki ^a   Aoshima, Yumie ^a   Hosaka, Nozomu ^a   Sanada, Daisuke ^a   Hirai, Yuki ^a   Shibata, Takanori ^a   Akizawa, Tadao ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CA 125; Hemodialysis; Soluble interleukin 2 receptor (sIL 2R); Tuberculous peritonitis

Indexed keywords

ADENOSINE DEAMINASE; C REACTIVE PROTEIN; CA 125 ANTIGEN; ELCATONIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; ZOLEDRONIC ACID;

ABDOMINAL DISCOMFORT; AGED; ANEMIA; ARTICLE; ASCITES; CARDIOMEGALY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPOALBUMINEMIA; KIDNEY FAILURE; MYCOBACTERIUM TUBERCULOSIS; NEPHROSCLEROSIS; PARACENTESIS; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY; TUBERCULOUS PERITONITIS;

AGED, 80 AND OVER; BIOLOGICAL MARKERS; CA-125 ANTIGEN; FEMALE; HUMANS; PERITONITIS, TUBERCULOUS; RECEPTORS, INTERLEUKIN-2; RENAL DIALYSIS; SOLUBILITY;

EID: 77956212777     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3760     Document Type: Article

References (16)

1. Fang HC, Lee PT, Chen CL, et al. Tuberculosis in patients with end-stage renal disease. Int J Tuberc Lung Dis 8: 92-97, 2004.
2. Chou KJ, Fang HC, Bai KJ, et al. Tuberculosis in maintenance dialysis patients. Nephron 88: 138-143, 2001.
3. Kart L, Buyukoglan H, Tekin IO, et al. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. Mediators Inflamm 12: 9-14, 2003.
4. Takahashi S, Setoguchi Y, Nukiwa T, et al. Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis. Chest 99: 310-314, 1991.
5. Chan CH, Lai KN, Leung JC, et al. T lymphocyte activation in patients with active tuberculosis. Am Rev Respir Dis 144: 458-460, 1991.
6. Chan CH, Lai CK, Leung JC, et al. Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy. Eur Respir J 8: 70-73, 1995.
7. Chang SC, Hsu YT, Chen YC, et al. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions. Arch Intern Med 154: 1097-1101, 1994.
8. Chiang CS, Chiang CD, Lin JW, et al. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions. Respiration 61: 150-154, 1994.
9. Porcel JM, Gazquez I, Vives M, et al. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid. Int J Tuberc Lung Dis 4: 975-979, 2000.
10. Shu KH, Lu YS, Cheng CH, et al. Soluble interleukin 2 receptor in dialyzed patients. Artif Organs 22: 142-144, 1998.
11. Simsek H, Savas MC, Kadayifci A, et al. Elevated serum CA 125 concentration in patients with tuberculous peritonitis: a casecontrol study. Am J Gastroenterol 92: 1174-1176, 1997.
12. Younossian AB, Rochat T, Favre L, et al. Ascites and highly elevated CA-125 levels in a case of peritoneal tuberculosis. Scand J Infect Dis 38: 216-218, 2006.
13. Kabawat SE, Bast RC Jr, Bhan AK, et al. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 2: 275-285, 1983.
14. Zeillemaker AM, Verbrugh HA, Leguit P. CA 125 secretion by peritoneal mesothelial cells. J Clin Pathol 47: 263-265, 1994.
15. Mas MR, Comert B, Saglamkaya U, et al. CA-125; a new marker for diagnosis and follow-up of patients with tuberculous peritonitis. Dig Liver Dis 32: 595-597, 2000.
16. Menzin AW, Kobrin S, Pollak E, et al. The effect of renal function on serum levels of CA 125. Gynecol Oncol 58: 375-377, 1995.